AAV's Golden Jubilee, Mol. Ther, vol.23, issue.5, pp.807-808, 2015. ,
Adeno-Associated Virus at 50: A Golden Anniversary of Discovery, Research, and Gene Therapy Success-A Personal Perspective, Hum. Gene Ther, vol.26, issue.5, pp.257-265, 2015. ,
Gene therapy enters the pharma market: The short story of a long journey: Gene therapy enters market, EMBO Mol. Med, vol.5, issue.1, pp.1-3, 2013. ,
Glybera and the future of gene therapy in the European Union, Nat. Rev. Drug Discov, vol.11, issue.5, p.419, 2012. ,
Endgame: Glybera Finally Recommended for Approval as the First Gene Therapy Drug in the European Union, Mol. Ther, vol.20, issue.10, pp.1831-1832, 2012. ,
The expanding range of parvoviruses which infect humans, Rev. Med. Virol, vol.20, issue.4, pp.231-244, 2010. ,
Adenovirus-Associated Defective Virus Particles, Science, vol.149, issue.3685, pp.754-755, 1965. ,
Studies of small DNA viruses found in various adenovirus preparations: physical, biological, and immunological characteristics, Proc. Natl. Acad. Sci. U. S. A, vol.55, issue.6, pp.1467-1474, 1966. ,
Association of 20-Millimicron Particles with Adenoviruses, J. Bacteriol, vol.90, issue.1, pp.271-274, 1965. ,
Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication, J. Virol, vol.40, issue.1, pp.241-247, 1981. ,
Human herpesvirus 6 (HHV-6) is a helper virus for adeno-associated virus type 2 (AAV-2) and the AAV-2 rep gene homologue in HHV-6 can mediate AAV-2 DNA replication and regulate gene expression, Virology, vol.204, issue.1, pp.304-311, 1994. ,
Vaccinia virus, herpes simplex virus, and carcinogens induce DNA amplification in a human cell line and support replication of a helpervirus dependent parvovirus, Virology, vol.152, issue.1, pp.110-117, 1986. ,
Interaction of human papillomavirus type 16 and adeno-associated virus type 2 co-infecting human cervical epithelium, J. Gen. Virol, vol.78, pp.1441-1452, 1997. ,
Worldwide Epidemiology of Neutralizing Antibodies to Adeno-Associated Viruses, J. Infect. Dis, vol.199, issue.3, pp.381-390, 2009. ,
Prevalence of Neutralizing Antibodies Against Adeno-Associated Virus (AAV) Types 2, 5, and 6 in Cystic Fibrosis and Normal Populations: Implications for Gene Therapy Using AAV Vectors, Hum. Gene Ther, vol.17, issue.4, pp.440-447, 2006. ,
Adeno-associated virus vectors for gene therapy, Gene Ther, vol.2, issue.6, pp.357-362, 1995. ,
Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy, J. Clin. Invest, vol.125, issue.2, pp.870-880, 2015. ,
Novel Tools for Production and Purification of Recombinant Adenoassociated Virus Vectors, Hum. Gene Ther, vol.9, issue.18, pp.2745-2760, 1998. ,
Clades of Adeno-Associated Viruses Are Widely Disseminated in Human Tissues, J. Virol, vol.78, issue.12, pp.6381-6388, 2004. ,
Adeno-associated Virus Serotypes: Vector Toolkit for Human Gene Therapy, Mol. Ther, vol.14, issue.3, pp.316-327, 2006. ,
Gene Therapy Using Adeno-Associated Virus Vectors, Clin. Microbiol. Rev, vol.21, issue.4, pp.583-593, 2008. ,
Adeno-associated virus serotypes for gene therapeutics, Curr. Opin. Pharmacol, vol.24, pp.59-67, 2015. ,
Intracellular transport of recombinant adeno-associated virus vectors, Gene Ther, vol.19, issue.6, pp.649-658, 2012. ,
An essential receptor for adeno-associated virus infection, Nature, vol.530, issue.7588, pp.108-112, 2016. ,
Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/-mice, Nat. Biotechnol, vol.25, issue.8, pp.903-910, 2007. ,
Tissue engineering by self-assembly and bio-printing of living cells, Biofabrication, vol.2, issue.2, p.22001, 2010. ,
Humoral immunity to AAV vectors in gene therapy: challenges and potential solutions, Discov. Med, vol.15, issue.85, pp.379-389, 2013. ,
Humoral Immune Response to AAV, Front. Immunol, vol.4, 2013. ,
Strategies to circumvent humoral immunity to adenoassociated viral vectors, Expert Opin. Biol. Ther, vol.15, issue.6, pp.845-855, 2015. ,
The AAV origin binding protein Rep68 is an ATP-dependent sitespecific endonuclease with DNA helicase activity, Cell, vol.61, issue.3, pp.447-457, 1990. ,
Identification of linear DNA sequences that specifically bind the adeno-associated virus Rep protein, J. Virol, vol.68, issue.8, pp.4988-4997, 1994. ,
Features of the adenoassociated virus origin involved in substrate recognition by the viral Rep protein, J. Virol, vol.67, issue.10, pp.6096-6104, 1993. ,
In vitro resolution of covalently joined AAV chromosome ends, Cell, vol.60, issue.1, pp.105-113, 1990. ,
A recombinant plasmid from which an infectious adenoassociated virus genome can be excised in vitro and its use to study viral replication, J. Virol, vol.61, issue.10, pp.3096-3101, 1987. ,
Adeno-associated virus general transduction vectors: analysis of proviral structures, J. Virol, vol.62, issue.6, pp.1963-1973, 1988. ,
The adeno-associated virus rep gene inhibits replication of an adeno-associated virus/simian virus 40 hybrid genome in cos-7 cells, J. Virol, vol.62, issue.5, pp.1705-1712, 1988. ,
Replication of a human parvovirus nonsense mutant in mammalian cells containing an inducible amber suppressor, Virology, vol.171, issue.1, pp.239-247, 1989. ,
Adeno-associated virus type 2 protein interactions: formation of pre-encapsidation complexes, J. Virol, vol.73, issue.11, pp.8989-8998, 1999. ,
DNA helicase-mediated packaging of adeno-associated virus type 2 genomes into preformed capsids, EMBO J, vol.20, issue.12, pp.3282-3291, 2001. ,
The bacteriophage straight phi29 portal motor can package DNA against a large internal force, Nature, vol.413, issue.6857, pp.748-752, 2001. ,
A viral assembly factor promotes AAV2 capsid formation in the nucleolus, Proc. Natl. Acad. Sci, vol.107, pp.10220-10225, 2010. ,
The Assembly-Activating Protein Promotes Capsid Assembly of Different Adeno-Associated Virus Serotypes, J. Virol, vol.85, issue.23, pp.12686-12697, 2011. ,
Direct mapping of adenoassociated virus capsid proteins B and C: a possible ACG initiation codon, Proc. Natl. Acad. Sci. U. S. A, vol.82, issue.23, pp.7919-7923, 1985. ,
Synthesis of adeno-associated virus structural proteins requires both alternative mRNA splicing and alternative initiations from a single transcript, J. Virol, vol.62, issue.8, pp.2745-2754, 1988. ,
The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity, J. Gen. Virol, vol.83, issue.5, pp.973-978, 2002. ,
Mutational Analysis of Narrow Pores at the Fivefold Symmetry Axes of Adeno-Associated Virus Type 2 Capsids Reveals a Dual Role in Genome Packaging and Activation of Phospholipase A2 Activity, J. Virol, vol.79, issue.4, pp.2528-2540, 2005. ,
A Conformational Change in the Adeno-Associated Virus Type 2 Capsid Leads to the Exposure of Hidden VP1 N Termini, J. Virol, vol.79, issue.9, pp.5296-5303, 2005. ,
Mapping a Neutralizing Epitope onto the Capsid of Adeno-Associated Virus Serotype 8, J. Virol, vol.86, issue.15, pp.7739-7751, 2012. ,
Structural Insight into the Unique Properties of Adeno-Associated Virus Serotype 9, J. Virol, vol.86, issue.12, pp.6947-6958, 2012. ,
Capsid Antibodies to Different Adeno-Associated Virus Serotypes Bind Common Regions, J. Virol, vol.87, issue.16, pp.9111-9124, 2013. ,
Structural Studies of Adeno-Associated Virus Serotype 8 Capsid Transitions Associated with Endosomal Trafficking, J. Virol, vol.85, issue.22, pp.11791-11799, 2011. ,
Structural Characterization of the Dual Glycan Binding Adeno-Associated Virus Serotype 6, J. Virol, vol.84, issue.24, pp.12945-12957, 2010. ,
Structurally Mapping the Diverse Phenotype of Adeno-Associated Virus Serotype 4, J. Virol, vol.80, issue.23, pp.11556-11570, 2006. ,
The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy, Proc. Natl. Acad. Sci, vol.99, issue.16, pp.10405-10410, 2002. ,
Mapping the AAV Capsid Host Antibody Response toward the Development of Second Generation Gene Delivery Vectors, Front. Immunol, vol.5, 2014. ,
Identification of Amino Acid Residues in the Capsid Proteins of Adeno-Associated Virus Type 2 That Contribute to Heparan Sulfate Proteoglycan Binding, J. Virol, vol.77, issue.12, pp.6995-7006, 2003. ,
Adeno-associated virus structural biology as a tool in vector development, Future Virol, vol.8, issue.12, pp.1183-1199, 2013. ,
Adeno-associated virus: fit to serve, Curr. Opin. Virol, vol.8, pp.90-97, 2014. ,
Electron cryo-microscopy and image reconstruction of adeno-associated virus type 2 empty capsids, EMBO Rep, vol.2, issue.11, pp.997-1002, 2001. ,
Physical virology, Nat. Phys, vol.6, issue.10, pp.733-743, 2010. ,
Bacteriophage capsids: Tough nanoshells with complex elastic properties, Proc. Natl. Acad. Sci, vol.101, issue.20, pp.7600-7605, 2004. ,
Internal DNA pressure modifies stability of WT phage, Proc. Natl. Acad. Sci, vol.104, pp.9603-9608, 2007. ,
Solid-to-fluid DNA transition inside HSV-1 capsid close to the temperature of infection, Nat. Chem. Biol, vol.10, issue.10, pp.861-867, 2014. ,
DNA-mediated anisotropic mechanical reinforcement of a virus, Proc. Natl. Acad. Sci, vol.103, issue.37, pp.13706-13711, 2006. ,
Manipulation of the mechanical properties of a virus by protein engineering, Proc. Natl. Acad. Sci, vol.105, issue.11, pp.4150-4155, 2008. ,
Comparative Analysis of Adeno-Associated Virus Capsid Stability and Dynamics, J. Virol, vol.87, issue.24, pp.13150-13160, 2013. ,
Biophysical and Ultrastructural Characterization of Adeno-Associated Virus Capsid Uncoating and Genome Release, J. Virol, vol.87, issue.6, pp.2994-3002, 2013. ,
Adeno-Associated Virus Capsid Proteins May Play a Role in Transcription and Second-Strand Synthesis of Recombinant Genomes, J. Virol, vol.88, issue.2, pp.1071-1079, 2014. ,
The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice, J. Clin. Invest, vol.119, issue.8, pp.2388-2398, 2009. ,
Unique Roles of TLR9-and MyD88-Dependent and -Independent Pathways in Adaptive Immune Responses to AAV-Mediated Gene Transfer, J. Innate Immun, vol.7, issue.3, pp.302-314, 2015. ,
In Silico Reconstruction of the Viral Evolutionary Lineage Yields a Potent Gene Therapy Vector, Cell Rep, vol.12, issue.6, pp.1056-1068, 2015. ,
Intracellular trafficking of adeno-associated viral vectors, Gene Ther, vol.12, issue.11, pp.873-880, 2005. ,
Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions, J. Virol, vol.72, issue.2, pp.1438-1445, 1998. ,
Identification of a Heparin-Binding Motif on Adeno-Associated Virus Type 2 Capsids, J. Virol, vol.77, issue.20, pp.11072-11081, 2003. ,
Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2, Nat. Med, vol.5, issue.1, pp.71-77, 1999. ,
AlphaVbeta5 integrin: a co-receptor for adenoassociated virus type 2 infection, Nat. Med, vol.5, issue.1, pp.78-82, 1999. ,
The 37/67-Kilodalton Laminin Receptor Is a Receptor for Adeno-Associated Virus Serotypes 8, 2, 3, and 9, J. Virol, vol.80, issue.19, pp.9831-9836, 2006. ,
Hepatocyte Growth Factor Receptor Is a Coreceptor for Adeno-Associated Virus Type 2 Infection, J. Virol, vol.79, issue.1, pp.609-614, 2005. ,
Real-Time Single-Molecule Imaging of the Infection Pathway of an Adeno-Associated Virus, Science, vol.294, issue.5548, pp.1929-1932, 2001. ,
Heparin binding induces conformational changes in Adeno-associated virus serotype 2, J. Struct. Biol, vol.165, issue.3, pp.146-156, 2009. ,
Adeno-Associated Virus Type 2 Contains an Integrin 5 1 Binding Domain Essential for Viral Cell Entry, J. Virol, vol.80, issue.18, pp.8961-8969, 2006. ,
Integrin ?V?5 Is Not Involved in Adeno-Associated Virus Type 2 (AAV2) Infection, Virology, vol.264, issue.2, pp.436-440, 1999. ,
Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus, J. Clin. Invest, vol.105, issue.11, pp.1573-1587, 2000. ,
Molecular characterization of adeno-associated viruses infecting children, J. Virol, vol.79, issue.23, pp.14781-14792, 2005. ,
Mechanisms of endocytosis, Annu. Rev. Biochem, vol.78, pp.857-902, 2009. ,
Pathways of clathrin-independent endocytosis, Nat. Rev. Mol. Cell Biol, vol.8, issue.8, pp.603-612, 2007. ,
Pathways of Antigen Processing, Annu. Rev. Immunol, vol.31, issue.1, pp.443-473, 2013. ,
Dynamin is required for recombinant adeno-associated virus type 2 infection, J. Virol, vol.73, issue.12, pp.10371-10376, 1999. ,
Successful target cell transduction of capsid-engineered rAAV vectors requires clathrin-dependent endocytosis, Gene Ther, vol.19, issue.2, pp.210-218, 2012. ,
Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation, J. Virol, vol.74, issue.19, pp.9184-9196, 2000. ,
Adeno-associated virus 2 infection requires endocytosis through the CLIC/GEEC pathway, Cell Host Microbe, vol.10, issue.6, pp.563-576, 2011. ,
BAAV transcytosis requires an interaction with beta-1-4 linked-glucosamine and gp96, PloS One, vol.5, issue.3, p.9336, 2010. ,
AAV transcytosis through barrier epithelia and endothelium, Mol. Ther. J. Am. Soc. Gene Ther, vol.13, issue.3, pp.506-516, 2006. ,
Analysis of AAV Serotypes 1-9 Mediated Gene Expression and Tropism in Mice After Systemic Injection, Mol. Ther, vol.16, issue.6, pp.1073-1080, 2008. ,
Comparative cardiac gene delivery of adeno-associated virus serotypes 1-9 reveals that AAV6 mediates the most efficient transduction in mouse heart, Clin. Transl. Sci, vol.3, issue.3, pp.81-89, 2010. ,
Adeno-Associated Virus Type 2 Capsids with Externalized VP1/VP2 Trafficking Domains Are Generated prior to Passage through the Cytoplasm and Are Maintained until Uncoating Occurs in the Nucleus, J. Virol, vol.80, issue.22, pp.11040-11054, 2006. ,
A Twohybrid Screen Identifies Cathepsins B and L as Uncoating Factors for Adeno-associated Virus 2 and 8, Mol. Ther, vol.15, issue.2, pp.330-339, 2007. ,
Rab proteins as membrane organizers, Nat. Rev. Mol. Cell Biol, vol.2, issue.2, pp.107-117, 2001. ,
Rab GTPases: specifying and deciphering organelle identity and function, Trends Cell Biol, vol.11, issue.12, pp.487-491, 2001. ,
rAAV2 traffics through both the late and the recycling endosomes in a dose-dependent fashion, Mol. Ther, vol.13, issue.4, pp.671-682, 2006. ,
Syntaxin 5-dependent retrograde transport to the trans-Golgi network is required for adeno-associated virus transduction, J. Virol, vol.89, issue.3, pp.1673-1687, 2015. ,
Adenovirus-Facilitated Nuclear Translocation of Adeno-Associated Virus Type 2, J. Virol, vol.76, issue.22, pp.11505-11517, 2002. ,
Cytoplasmic Trafficking, Endosomal Escape, and Perinuclear Accumulation of Adeno-Associated Virus Type 2 Particles Are Facilitated by Microtubule Network, J. Virol, vol.86, issue.19, pp.10462-10473, 2012. ,
The ubiquitin proteasome system and efficacy of proteasome inhibitors in diseases, Int. J. Rheum. Dis, vol.15, issue.3, pp.249-260, 2012. ,
Tyrosinephosphorylation of AAV2 vectors and its consequences on viral intracellular trafficking and transgene expression, Virology, vol.381, issue.2, pp.194-202, 2008. ,
A 110-kDa nuclear shuttle protein, nucleolin, specifically binds to adenoassociated virus type 2 (AAV-2) capsid, Virology, vol.257, issue.2, pp.373-382, 1999. ,
Mutagenesis of Adeno-Associated Virus Type 2 Capsid Protein VP1 Uncovers New Roles for Basic Amino Acids in Trafficking and Cell-Specific Transduction, J. Virol, vol.84, issue.17, pp.8888-8902, 2010. ,
Ubiquitination of both Adeno-Associated Virus Type 2 and 5 Capsid Proteins Affects the Transduction Efficiency of Recombinant Vectors, J. Virol, vol.76, issue.5, pp.2043-2053, 2002. ,
Intrinsic phospholipase A2 activity of adeno-associated virus is involved in endosomal escape of incoming particles, Virology, vol.409, issue.1, pp.77-83, 2011. ,
Infectious Entry Pathway of Adeno-Associated Virus and Adeno-Associated Virus Vectors, J. Virol, vol.74, issue.6, pp.2777-2785, 2000. ,
Green Fluorescent Protein-Tagged Adeno-Associated Virus Particles Allow the Study of Cytosolic and Nuclear Trafficking, J. Virol, vol.79, issue.18, pp.11776-11787, 2005. ,
Separate Basic Region Motifs within the Adeno-Associated Virus Capsid Proteins Are Essential for Infectivity and Assembly, J. Virol, vol.80, issue.11, pp.5199-5210, 2006. ,
Recombinant adeno-associated virus utilizes host cell nuclear import machinery to enter the nucleus, J. Virol, vol.88, issue.8, pp.4132-4144, 2014. ,
Superresolution imaging of nuclear import of adeno-associated virus in live cells, Mol. Ther. Methods Clin. Dev, vol.2, p.15047, 2015. ,
Nuclear envelope disruption involving host caspases plays a role in the parvovirus replication cycle, J. Virol, vol.85, issue.10, pp.4863-4874, 2011. ,
Parvoviruses Cause Nuclear Envelope Breakdown by Activating Key Enzymes of Mitosis, PLoS Pathog, vol.9, issue.10, p.1003671, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01101277
Infection of Purified Nuclei by Adeno-associated Virus 2, Mol. Ther, vol.4, issue.4, pp.289-296, 2001. ,
Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors, J. Virol, vol.78, issue.6, pp.3110-3122, 2004. ,
Differential internalization and nuclear uncoating of self-complementary adeno-associated virus pseudotype vectors as determinants of cardiac cell transduction, Gene Ther, 2007. ,
Enhancement of Adeno-Associated Virus Infection by Mobilizing Capsids into and Out of the Nucleolus, J. Virol, vol.83, issue.6, pp.2632-2644, 2009. ,
Adenoassociated virus interactions with B23/Nucleophosmin: identification of sub-nucleolar virion regions, Virology, vol.357, issue.1, pp.102-113, 2007. ,
Adeno-Associated Virus: A Ubiquitous Commensal of Mammals, Hum. Gene Ther, vol.16, issue.4, pp.401-407, 2005. ,
Prospects for the use of adeno-associated virus as a vector for human gene therapy, Hum. Gene Ther, vol.5, issue.7, pp.793-801, 1994. ,
Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors, J. Virol, vol.70, issue.5, pp.3227-3234, 1996. ,
Structures and functions of parvovirus capsids and the process of cell infection, Curr. Top. Microbiol. Immunol, vol.343, pp.149-176, 2010. ,
Targeted integration of adeno-associated virus (AAV) into human chromosome 19, EMBO J, vol.10, issue.12, pp.3941-3950, 1991. ,
Cellular recombination pathways and viral terminal repeat hairpin structures are sufficient for adeno-associated virus integration in vivo and in vitro, J. Virol, vol.71, issue.12, pp.9231-9247, 1997. ,
Recombinant Adeno-associated Virus Transduction and Integration, Mol. Ther, vol.16, issue.7, pp.1189-1199, 2008. ,
Mechanism of Rep-mediated adeno-associated virus origin nicking, J. Virol, vol.74, issue.17, pp.7762-7771, 2000. ,
Adeno-associated virus rep protein synthesis during productive infection, J. Virol, vol.63, issue.2, pp.873-882, 1989. ,
Adeno-associated virus gene expression inhibits cellular transformation by heterologous genes, Mol. Cell. Biol, vol.7, issue.4, pp.1320-1325, 1987. ,
Helper functions required for wild type and recombinant adenoassociated virus growth, Curr. Gene Ther, vol.5, issue.3, pp.265-271, 2005. ,
Mechanisms of adenoassociated virus genome encapsidation, Curr. Gene Ther, vol.5, issue.3, pp.273-284, 2005. ,
Custom Adeno-Associated Virus Capsids: The Next Generation of Recombinant Vectors with Novel Tropism, Hum. Gene Ther, vol.16, issue.4, pp.408-416, 2005. ,
Surface-Engineered Viral Vectors for Selective and Cell Type-Specific Gene Delivery, Trends Biotechnol, vol.33, issue.12, pp.777-790, 2015. ,
History of gene therapy, Gene, vol.525, issue.2, pp.162-169, 2013. ,
Human gene transfer test approved, Science, vol.243, issue.4890, p.473, 1989. ,
Gene Transfer into Humans -Immunotherapy of Patients with Advanced Melanoma, Using Tumor-Infiltrating Lymphocytes Modified by Retroviral Gene Transduction, N. Engl. J. Med, vol.323, issue.9, pp.570-578, 1990. ,
T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years, Science, vol.270, issue.5235, pp.475-480, 1995. ,
Gene Therapy for the Treatment of Primary Immune Deficiencies, Curr. Allergy Asthma Rep, vol.16, issue.5, 2016. ,
Gene Therapy: Design and Prospects for Craniofacial Regeneration, J. Dent. Res, vol.88, issue.7, pp.585-596, 2009. ,
Clinical gene therapy using recombinant adeno-associated virus vectors, Gene Ther, vol.15, issue.11, pp.858-863, 2008. ,
Adeno-associated Virus as a Mammalian DNA Vector, Microbiol. Spectr, vol.3, issue.4, 2015. ,
,
Overcoming Preexisting Humoral Immunity to AAV Using Capsid Decoys, Sci. Transl. Med, vol.5, issue.194, pp.194-92, 2013. ,
Adenovirus-Associated Virus Vector-Mediated Gene Transfer in Hemophilia B, N. Engl. J. Med, vol.365, issue.25, pp.2357-2365, 2011. ,
Protection Against Henipavirus Infection by Use of Recombinant Adeno-Associated Virus-Vector Vaccines, J. Infect. Dis, vol.207, issue.3, pp.469-478, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00965033
AAV Vectors Vaccines Against Infectious Diseases, Front. Immunol, vol.5, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-00965088
Genetic immunization with adeno-associated virus vectors expressing herpes simplex virus type 2 glycoproteins B and D, J. Virol, vol.71, issue.10, pp.7960-7962, 1997. ,
A Novel Recombinant Adeno-Associated Virus Vaccine Induces a Long-Term Humoral Immune Response to Human Immunodeficiency Virus, Hum. Gene Ther, vol.12, issue.9, pp.1047-1061, 2001. ,
Cell-Mediated Immunity to AAV Vectors, Evolving Concepts and Potential Solutions, Front. Immunol, vol.5, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01321133
Little Vector, Big Gene Transduction: Fragmented Genome Reassembly of Adeno-associated Virus, Mol. Ther, vol.18, issue.1, pp.6-8, 2010. ,
Trans-splicing vectors expand the utility of adenoassociated virus for gene therapy, Proc. Natl. Acad. Sci. U. S. A, vol.97, issue.12, pp.6716-6721, 2000. ,
Effect of Genome Size on AAV Vector Packaging, Mol. Ther, vol.18, issue.1, pp.80-86, 2010. ,
Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors, Gene Therapy for Neurological Disorders, vol.1382, pp.21-39, 2016. ,
Self-complementary recombinant adenoassociated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis, Gene Ther, vol.8, issue.16, pp.1248-1254, 2001. ,
Self-Complementary Recombinant Adeno-Associated Viral Vectors: Packaging Capacity And The Role of Rep Proteins in Vector Purity, Hum. Gene Ther, vol.18, issue.2, pp.171-182, 2007. ,
Promoters and control elements: designing expression cassettes for gene therapy, Curr. Gene Ther, vol.4, issue.1, pp.89-113, 2004. ,
Selective transgene expression in cerebellar Purkinje cells and granule cells using adeno-associated viruses together with specific promoters, Brain Res, vol.1620, pp.1-16, 2015. ,
Targeted genetic manipulations of neuronal subtypes using promoter-specific combinatorial AAVs in wild-type animals, Front. Behav. Neurosci, vol.9, 2015. ,
AAV-mediated transduction and targeting of retinal bipolar cells with improved mGluR6 promoters in rodents and primates, Gene Ther, 2016. ,
Generation and characterization of chimeric recombinant AAV vectors, Mol. Ther. J. Am. Soc. Gene Ther, vol.7, issue.3, pp.419-425, 2003. ,
Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups, J. Virol, vol.78, issue.9, pp.4421-4432, 2004. ,
Marker rescue of adeno-associated virus (AAV) capsid mutants: a novel approach for chimeric AAV production, J. Virol, vol.77, issue.1, pp.423-432, 2003. ,
Characterization of the Relationship of AAV Capsid Domain Swapping to Liver Transduction Efficiency, Mol. Ther, vol.15, issue.11, pp.1955-1962, 2007. ,
Combinatorial engineering of a gene therapy vector: directed evolution of adeno-associated virus, J. Gene Med, vol.8, issue.2, pp.155-162, 2006. ,
Directed evolution of adenoassociated virus yields enhanced gene delivery vectors, Nat. Biotechnol, vol.24, issue.2, pp.198-204, 2006. ,
Engineering the AAV capsid to optimize vector-host-interactions, Curr. Opin. Pharmacol, vol.24, pp.94-104, 2015. ,
Artificial evolution with adenoassociated viral libraries, Comb. Chem. High Throughput Screen, vol.11, issue.2, pp.118-126, 2008. ,
Innate Immune Responses to AAV Vectors, Front. Microbiol, vol.2, 2011. ,
CELL BIOLOGY OF ANTIGEN PROCESSING IN VITRO AND IN VIVO, Annu. Rev. Immunol, vol.23, issue.1, pp.975-1028, 2005. ,
Molecular Control of Steady-State Dendritic Cell Maturation and Immune Homeostasis, Annu. Rev. Immunol, vol.31, issue.1, pp.743-791, 2013. ,
Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors, J. Virol, vol.76, issue.9, pp.4580-4590, 2002. ,
Complement is an essential component of the immune response to adenoassociated virus vectors, J. Virol, vol.82, issue.6, pp.2727-2740, 2008. ,
Toll-like receptor 2-mediated innate immune response in human nonparenchymal liver cells toward adenoassociated viral vectors, Hepatology, vol.55, issue.1, pp.287-297, 2012. ,
The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9-dependent innate immune responses in the liver, Blood, vol.117, issue.24, pp.6459-6468, 2011. ,
Adenoassociated virus capsid antigen presentation is dependent on endosomal escape, J. Clin. Invest, vol.123, issue.3, pp.1390-1401, 2013. ,
Capsid antigen presentation flags human hepatocytes for destruction after transduction by adeno-associated viral vectors, J. Clin. Invest, vol.119, issue.6, pp.1688-1695, 2009. ,
Proteasome inhibitors decrease AAV2 capsid derived peptide epitope presentation on MHC class I following transduction, Mol. Ther. J. Am. Soc. Gene Ther, vol.18, issue.1, pp.135-142, 2010. ,
The complex and evolving story of T cell activation to AAV vectorencoded transgene products, Mol. Ther. J. Am. Soc. Gene Ther, vol.19, issue.1, pp.16-27, 2011. ,
Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV), J. Med. Virol, vol.59, issue.3, pp.406-411, 1999. ,
Neutralizing antibodies against adeno-associated virus examined prospectively in pediatric patients with hemophilia, Gene Ther, vol.19, issue.3, pp.288-294, 2012. ,
Adeno-associated virus antibody profiles in newborns, children, and adolescents, Clin. Vaccine Immunol. CVI, vol.18, issue.9, pp.1586-1588, 2011. ,
Immune responses to AAV vectors: overcoming barriers to successful gene therapy, Blood, vol.122, issue.1, pp.23-36, 2013. ,
Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response, Nat. Med, vol.12, issue.3, pp.342-347, 2006. ,
Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges, Nat. Rev. Genet, vol.12, issue.5, pp.341-355, 2011. ,
Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells, Blood, vol.121, issue.12, pp.2224-2233, 2013. ,
AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells, Blood, vol.114, issue.10, pp.2077-2086, 2009. ,
Immunology of AAV-Mediated Gene Transfer in the Eye, Front. Immunol, vol.4, 2013. ,
Next generation of adeno-associated virus 2 vectors: Point mutations in tyrosines lead to high-efficiency transduction at lower doses, Proc. Natl. Acad. Sci, vol.105, issue.22, pp.7827-7832, 2008. ,
Modulation of CD8+ T cell responses to AAV vectors with IgG-derived MHC class II epitopes, Mol. Ther, vol.21, issue.9, 2013. ,
Activation of natural regulatory T cells by IgG Fc-derived peptide 'Tregitopes, Blood, vol.112, issue.8, pp.3303-3311, 2008. ,
Induction of antigen-specific CD4+ T-cell anergy and deletion by in vivo viral gene transfer, Blood, vol.104, issue.4, pp.969-977, 2004. ,
Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer, J. Clin. Invest, vol.111, issue.9, pp.1347-1356, 2003. ,
Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transfer, Blood, vol.110, issue.4, pp.1132-1140, 2007. ,
Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver, Blood, vol.110, issue.7, pp.2334-2341, 2007. ,
Antigen-presenting cell function in the tolerogenic liver environment, Nat. Rev. Immunol, vol.10, issue.11, pp.753-766, 2010. ,
Evasion of Immune Responses to Introduced Human Acid ?-Glucosidase by Liver-Restricted Expression in Glycogen Storage Disease Type II, Mol. Ther, vol.12, issue.5, pp.876-884, 2005. ,
AAV2 Vector Harboring a Liver-Restricted Promoter Facilitates Sustained Expression of Therapeutic Levels of ?-Galactosidase A and the Induction of Immune Tolerance in Fabry Mice, Mol. Ther, vol.9, issue.2, pp.231-240, 2004. ,
Dystrophin Immunity in Duchenne's Muscular Dystrophy, N. Engl. J. Med, vol.363, issue.15, pp.1429-1437, 2010. ,
Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1, Blood, vol.103, issue.1, pp.85-92, 2004. ,
Influence of Vector Dose on Factor IX-Specific T and B Cell Responses in Muscle-Directed Gene Therapy, Hum. Gene Ther, vol.13, issue.11, pp.1281-1291, 2002. ,
Muscle-Directed Gene Transfer and Transient Immune Suppression Result in Sustained Partial Correction of Canine Hemophilia B Caused by a Null Mutation, Mol. Ther, vol.4, issue.3, pp.192-200, 2001. ,
Dendritic cell biology, Adv. Immunol, vol.88, pp.193-233, 2005. ,
Dendritic cells: translating innate to adaptive immunity, Curr. Top. Microbiol. Immunol, vol.311, pp.17-58, 2006. ,
Dendritic Cells: Immune Regulators in Health and Disease, Physiol. Rev, vol.82, issue.1, pp.97-130, 2002. ,
Major Subsets of Human Dendritic Cells Are Efficiently Transduced by Self-Complementary Adeno-Associated Virus Vectors 1 and 2, J. Virol, vol.81, issue.10, pp.5385-5394, 2007. ,
CD40 ligand-dependent activation of cytotoxic T lymphocytes by adeno-associated virus vectors in vivo: role of immature dendritic cells, J. Virol, vol.74, issue.17, pp.8003-8010, 2000. ,
Adeno-associated virus type 2-mediated transduction of human monocyte-derived dendritic cells: implications for ex vivo immunotherapy, J. Virol, vol.75, issue.19, pp.9493-9501, 2001. ,
Effective transduction by self-complementary adeno-associated viruses of human dendritic cells with no alteration of their natural characteristics, J. Gene Med, vol.10, issue.7, pp.762-769, 2008. ,
Induction of Robust Immune Responses against Human Immunodeficiency Virus Is Supported by the Inherent Tropism of Adeno-Associated Virus Type 5 for Dendritic Cells, J. Virol, vol.80, issue.24, pp.11899-11910, 2006. ,
High-efficiency transduction of human monocytederived dendritic cells by capsid-modified recombinant AAV2 vectors, Vaccine, vol.30, issue.26, pp.3908-3917, 2012. ,
Development of novel AAV serotype 6 based vectors with selective tropism for human cancer cells, Gene Ther, vol.23, issue.1, pp.18-25, 2016. ,
Reprogramming Immune Response With Capsid-Optimized AAV6 Vectors for Immunotherapy of Cancer, J. Immunother, vol.38, issue.7, pp.292-298, 2015. ,
Early Interaction of Adeno-Associated Virus Serotype 8 Vector with the Host Immune System Following Intramuscular Delivery Results in Weak but Detectable Lymphocyte and Dendritic Cell Transduction, Hum. Gene Ther, vol.26, issue.1, pp.1-13, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-01734763
AAV8 Induces Tolerance in Murine Muscle as a Result of Poor APC Transduction, T Cell Exhaustion, and Minimal MHCI Upregulation on Target Cells, Mol. Ther, vol.22, issue.1, pp.28-41, 2014. ,
Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus, J. Virol, vol.72, issue.3, pp.2224-2232, 1998. ,
Factors Influencing Recombinant Adeno-Associated Virus Production, Hum. Gene Ther, vol.9, issue.5, pp.695-706, 1998. ,
Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield, Gene Ther, vol.6, issue.6, pp.973-985, 1999. ,
Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2, Nat. Med, vol.5, issue.12, p.1438, 1999. ,
Efficient and Selective AAV2-Mediated Gene Transfer Directed to Human Vascular Endothelial Cells, Mol. Ther, vol.4, issue.3, pp.174-181, 2001. ,
Intrinsic transgene immunogenicity gears CD8(+) T-cell priming after rAAV-mediated muscle gene transfer, Mol. Ther. J. Am. Soc. Gene Ther, vol.23, issue.4, pp.697-706, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02407918
In vitro selection of viral vectors with modified tropism: the adeno-associated virus display, Mol. Ther, vol.8, issue.1, pp.151-157, 2003. ,
Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection, J. Virol, vol.74, issue.19, pp.9281-9293, 2000. ,
Oral-tolerization Prevents Immune Responses and Improves Transgene Persistence Following Gene Transfer Mediated by Adeno-associated Viral Vector, Mol. Ther, vol.24, issue.1, pp.87-95, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-02377462
Dendritic cells-At the front-line of pathogen attack, Vet. Immunol. Immunopathol, vol.128, issue.1-3, pp.7-15, 2009. ,
Differential Lysosomal Proteolysis in Antigen-Presenting Cells Determines Antigen Fate, Science, vol.307, issue.5715, pp.1630-1634, 2005. ,
Regulated Assembly of Vacuolar ATPase Is Increased during Cluster Disruption-induced Maturation of Dendritic Cells through a Phosphatidylinositol 3-Kinase/mTOR-dependent Pathway, J. Biol. Chem, vol.289, issue.3, pp.1355-1363, 2014. ,
Phagocytosis and antigen presentation in dendritic cells, Immunol. Rev, vol.219, issue.1, pp.143-156, 2007. ,
NOX2 Controls Phagosomal pH to Regulate Antigen Processing during Crosspresentation by Dendritic Cells, Cell, vol.126, issue.1, pp.205-218, 2006. ,
The Small GTPase Rac2 Controls Phagosomal Alkalinization and Antigen Crosspresentation Selectively in CD8+ Dendritic Cells, Immunity, vol.30, issue.4, pp.544-555, 2009. ,
Genetic Fate of Recombinant Adeno-Associated Virus Vector Genomes in Muscle, J. Virol, vol.77, issue.6, pp.3495-3504, 2003. ,
Imaging Biological Samples with Atomic Force Microscopy, p. pdb.top080473, vol.2014, 2014. ,
Sustained Whole-Body Functional Rescue in Congestive Heart Failure and Muscular Dystrophy Hamsters by Systemic Gene Transfer, Circulation, vol.112, issue.17, pp.2650-2659, 2005. ,
Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart, Nat. Biotechnol, vol.23, issue.3, pp.321-328, 2005. ,
Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8, Mol. Ther. J. Am. Soc. Gene Ther, vol.14, issue.1, pp.45-53, 2006. ,
A potential role of distinctively delayed blood clearance of recombinant adeno-associated virus serotype 9 in robust cardiac transduction, Mol. Ther. J. Am. Soc. Gene Ther, vol.19, issue.6, pp.1079-1089, 2011. ,
Spinal AMPA receptor inhibition attenuates mechanical allodynia and neuronal hyperexcitability following spinal cord injury in rats, J. Neurosci. Res, vol.85, issue.11, pp.2352-2359, 2007. ,
Microglial polarization and plasticity: Evidence from organotypic hippocampal slice cultures: Microglial Polarization and Tolerization, Glia, vol.61, issue.10, pp.1698-1711, 2013. ,
Degradation of proteoglycans affects astrocytes and neurite formation in organotypic tissue cultures, Brain Res, vol.1564, pp.22-32, 2014. ,
Associated occurrence of p75 neurotrophin receptor expressing aldynoglia and microglia/macrophages in long term organotypic murine brain slice cultures, Brain Res, vol.1595, pp.29-42, 2015. ,
Modulating the Function of the Measles Virus RNA-Dependent RNA Polymerase by Insertion of Green Fluorescent Protein into the Open Reading Frame, J. Virol, vol.76, issue.14, pp.7322-7328, 2002. ,
, plus précisément le Dr Cendrine Moskalenko et son équipe qui m'ont permis d'aborder des thématiques transdisciplinaires que je trouve passionnantes. J'aimerais donc remercier Cendrine, Julien Bernaud, Anny Fis et Jorge Rodriguez Ramos pour leur enthousiasme à étudier les propriétés physiques et mécaniques des vecteurs AAV. Je reste convaincu que ces travaux auront d'importantes conséquences sur la manière de designer les vecteurs viraux à l'avenir
, Je souhaite également remercier l'institut de recherche et d'innovation biomédicale (iRiB), plus précisément le Dr Sahil Adriouch et Léa Dupaty pour leur importante contribution dans la caractérisation immunologique in vivo du mutant sélectionné, Je voudrais les remercier pour les différents échanges passionnants que nous avons eus ces derniers mois
, Pour finir je souhaite remercier le collectif Mauvaise Foi, plus précisément Rémy Mattei (qui ne sait peut-être pas encore complètement dans quoi il a mis les pieds) pour notre projet de vulgarisation scientifique, portant sur le transfert de gène médié par les vecteurs viraux en bande dessinée. Je remercie donc Rémy pour son implication. Sa rapidité à comprendre les concepts biologique et son immense talent d'illustrateur permettront, j'en suis sûr, de mener à bien ce projet
, I also want to thank my personal proofreader, Manon Grosmaire for the hard work she have executed to read, understand and correct my manuscript
, plus précisément Thibaut Deschamps, Vincent Grass, Chloé Mengardi et Sonia Assil toujours motivés, disponibles et enthousiastes pour initier de nouvelles collaborations ou se lancer dans des initiatives estudiantines diverses et variées. Leur présence au sein du CIRI a permis, en ce qui me concerne, J'aimerais remercier l'association des doctorants du CIRI (CIRI'Pamp)
,
, Cette liste serait incomplète si je ne remerciais pas les personnes qui compte le plus pour moi, l'ensemble des personnes qui font que je me tiens encore debout aujourd'hui et que j'aime le plus, ma famille et mon « sanctuaire », sans eux qui me suivent depuis plusieurs années, la question de devenir ou non Docteur ne se serait certainement jamais posée
, Je souhaite également remercier l'accueil du Dr Théophile Ohlmann et du Dr François-Loïc Cosset qui m'ont permis de finir ma thèse au sein du CIRI
, J'aimerais finaliser mes remerciements en citant la Région Rhône-Alpes (ARC-1 : Infectiologie) pour avoir financé mon projet de recherche ainsi que mon projet de vulgarisation scientifique